Newsroom
Post Market Movers: CVS Health Supports Customers Amid California Wildfires
By KlickAnalytics Data Insights | January 10, 2025 08:09PM ET
Key Points
- CVS Health is actively supporting customers, patients, members, and colleagues during the California wildfires
- Despite facing significant headwinds and a 43% stock decline, CVS Health still offers an attractive 5.8% dividend yield
- The company faces strong competition from Amazon, Walmart, and Costco, impacting market share
- CVS Health saw double-digit revenue growth in two of its three segments
- The pharmacy market share for CVS Health slightly increased to 27.3%
CVS Health is standing by its customers, patients, members, and colleagues in response to the devastating California wildfires. Despite facing challenges such as a significant stock decline of 43%, the company continues to offer an attractive 5.8% dividend yield. This yield is considered safe with a well-covered payout ratio of 55.9%.
The presence of strong competitors such as Amazon, Walmart, and Costco has impacted CVS Health's market share. As a result, the company has revised its cash flow guidance down to $9.0 billion. However, CVS Health managed to achieve double-digit revenue growth in two out of its three segments, showcasing its resilience in the face of tough competition.
One positive note for CVS Health is the slight increase in pharmacy market share to 27.3%. This growth indicates that despite the challenges, the company is still making strides in the industry. Overall, CVS Health's commitment to supporting its customers and dedication to navigating through challenging times positions the company as a strong player in the healthcare sector.
About CVS
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.For more information:
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with